You are here

United States

Vaccines: Johnson @Johnson and Novavax report contracts, developments

 

NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Study on the risk of COVID-19 among front-line health workers compared with thegeneral community

http://www.thelancet-press.com/embargo/hcwcovid.pdf

Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study

Summary Background Data for front-line health-care workers and risk of COVID-19 are limited. We sought to assess risk of COVID-19 among front-line health-care workers compared with the general community and the effect of personal protective equipment (PPE) on risk.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

TB, Malaria and H.I.V. are spreading amid the coronavirus pandemic

It begins with a mild fever and malaise, followed by a painful cough and shortness of breath. The infection prospers in crowds, spreading to people in close reach. Containing an outbreak requires contact tracing, as well as isolation and treatment of the sick for weeks or months.

This insidious disease has touched every part of the globe. It is tuberculosis, the biggest infectious-disease killer worldwide, claiming 1.5 million lives each year.

Problem, Solution, SitRep, or ?: 

Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.

The company recently began a clinical trial in Europe and the United States to test its vaccine in people. It is one of more than 30 human trials for coronavirus vaccines underway across the world. But until these trials are complete — which will probably take several months — the monkey data offers the best clues to whether the vaccines will work.

Problem, Solution, SitRep, or ?: 

U.K. to start distributing 90 minute coronavirus and flu tests.

New 90-minute tests that can detect coronavirus and flu will be rolled out in hospitals and care homes from next week.

The "on-the-spot" swab and DNA tests will help distinguish between Covid-19 and other seasonal illnesses, the government said.

The health secretary said this would be "hugely beneficial" over the winter.

Currently, a third of tests take longer than 24 hours to process.

Problem, Solution, SitRep, or ?: 

Scientists Worry About Political Influence Over Coronavirus Vaccine Project

 

In April, with hospitals overwhelmed and much of the United States in lockdown, the Department of Health and Human Services produced a presentation for the White House arguing that rapid development of a coronavirus vaccine was the best hope to control the pandemic.

“DEADLINE: Enable broad access to the public by October 2020,” the first slide read, with the date in bold.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to United States
howdy folks